Twist announces Q2 financial results
May 7, 2021 -- Twist Bioscience announced that revenues grew in the company's second quarter of fiscal 2021, although the firm's net loss also grew. Read More
Evotec, BMS debut program to speed academic translational research
May 7, 2021 -- Evotec announced on May 6 a new program that aims to accelerate translational research from the U.K.'s academic life science ecosystem in collaboration with Bristol-Myers Squibb (BMS). Read More
CRISPR Therapeutics, Nkarta partner on gene edited cancer therapies
May 7, 2021 -- CRISPR Therapeutics has established a strategic partnership with Nkarta to research, develop, and commercialize CRISPR/Cas9 gene edited cell therapies for cancer. Read More
Bio-Techne posts revenue gains in Q3
May 6, 2021 -- Bio-Techne reported strong growth in revenues for its third quarter, thanks largely to sales in its protein analysis business. Read More
Sanofi, Stanford partner to study immunology
May 6, 2021 -- Sanofi has entered into a three-year research collaboration with the Stanford University School of Medicine to advance the understanding of immunology and inflammation. Read More
Dyno Therapeutics nabs $100M for AI gene therapy platform
May 6, 2021 -- Dyno Therapeutics has closed $100 million in financing to expand its CapsidMap platform, which uses artificial intelligence (AI) technology to design novel adeno-associated virus gene therapy vectors, thereby enhancing the therapeutic effect of gene therapies. Read More
Errant Gene Therapeutics changes name to San Rocco Therapeutics
May 5, 2021 -- Errant Gene Therapeutics, founded in 1993 after founder Pat Girondi's son was diagnosed with thalassemia, will become San Rocco Therapeutics, after San Rocco, the patron saint of hopeless disease. Read More
PerkinElmer posts major gains in Q1
May 5, 2021 -- PerkinElmer reported sharp increases in revenues and net income for the first quarter of 2021. Read More
Crown Bioscience acquires in vitro services provider OcellO
May 5, 2021 -- Crown Bioscience, a JSR Life Sciences company, has acquired OcellO, a privately owned contract research organization in the Netherlands. Read More
Qiagen posts strong sales, earnings growth in Q1
May 4, 2021 -- Strong growth in both COVID-19 and non-COVID-19 product groups propelled Qiagen to a 48% increase in net sales at constant exchange rates in its first quarter. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter